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A B S T R A C T Rabbit transferrin in vitro is shown to
load ferrous iron at random on its specific binding sites.
The release of iron to reticulocytes is shown to be an
all-or-none phenomenon. The two monoferric trans-
ferrins have similar in vivo plasma iron clearance rates
and tissue distribution. Diferric transferrin, while giv-
ing a similar tissue distribution of radioiron, has a
plasma iron clearance rate approximately twice that
of the monoferric transferrins at low plasma iron con-
centrations. This difference diminishes as the plasma
iron concentration increases. These results are consis-
tent with a progressively greater in vivo conversion of
mono- to diferric transferrin as transferrin saturation
increases. The in vivo plasma iron turnover in the rab-
bit increases progressively as the plasma iron increases,
from a mean value of -0.8 mg/dl whole blood per
d at a plasma iron concentration of 50 ug/dl to 2.0 at
a plasma iron concentration of 300.
The molecular behavior of transferrin and its iron
over this range was investigated using '251-transferrin,
[55Fe]monoferric transferrin, and [59Fe]diferric trans-
ferrin. The equilibrium distribution of transferrin be-
tween its apo-, mono-, and diferric moieties was sim-
ilar to that predicted on the basis of the percent sat-
uration and random distribution. Rate constants of
iron loading and unloading calculated from the percent
saturation and from the clearance rates of [55Fe]-
monoferric and [59Fe]diferric transferrin were similar
to those derived from changes in injected '251-apo-
transferrin. On the basis of these data, it is concluded
that the plasma transferrin pool is nonhomogeneous
and that the relative size of the mono- and diferric
cycles depends on transferrin saturation. A formula is
proposed for correcting the plasma iron turnover,
thereby eliminating the effect of plasma iron concen-
tration, so as to reflect directly the number of tissue
transferrin receptors.
Received for publication 20 April 1982 and in revised
form 12 July 1982.
INTRODUCTION
Although pathways of iron exchange between tissues
have been defined (1), the behavior of the plasma iron
transport protein itself has been under question (2).
Recently, methods have been developed (3, 4) that
make possible preparation of pure fractions of apo-,
mono-, and diferric transferrin. Analytic procedures
including both isoelectric focussing and gel electro-
phoresis permit quantitation of the different species
of transferrin as they exist in the plasma. A recent
report of such measurements in rabbits presented ev-
idence that transferrin iron did not behave as a ho-
mogeneous pool (5). The present study characterizes
in more detail the in vitro and in vivo exchange of
iron with transferrin and establishes a model in the
normal rabbit whereby transferrin iron exchange at
any given concentration of plasma iron may be de-
scribed.
METHODS
Transferrin was isolated from 275 ml normal rabbit plasma
after iron saturation with ferrous ammonium sulfate under
spectrophotometric control (3). The separation procedure by
means of gel chromatography on Sephacryl S200, ion ex-
change chromatography on DEAE Sephacel, and conversion
of the diferric into the apotransferrin form was the same as
described for human transferrin (4). Isolation of apo-,
mono-, and diferric transferrin was carried out by isoelectric
focussing procedures identical to those described for human
transferrin (3, 4). In this instance, the starting material was
200 mg of rabbit apotransferrin one-third saturated with
55Fe or 59Fe-tagged ferrous ammonium sulfate. lodination
of the diferric transferrin was carried out as described else-
where (6). The various transferrin preparations were stored
in 0.05 M Hepes buffer saline, pH 7.4, at 4°C. Under these
conditions the preparations were stable for at least 2 mo.
Quantitation of the various transferrin fractions and their
radioactivity was carried out by urea gel electrophoresis.
The method of Makey and Seal (7) with some modification
was used. Reagents were prepared with iron-free water and
further treated to remove any contaminating iron. The ac-
rylamide, bis-acrylamide, and 10 M urea solutions were each
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mixed for 2 h with 50 g/liter of a mixed bed resin (AG 501-
X8 Bio-Rad Laboratories, Richmond, CA), filtered and
stored at 4°C. The boric acid buffer, pH 8.4, and the sucrose-
containing diluting buffer were mixed, 25 g/liter, with a
chelating resin (Chelex 100, Bio-Rad Laboratories) for 2 h,
then filtered. Other reagents used were checked for iron
contamination. In the actual procedure, acrylamide gels con-
taining 6 M urea were prepared in 13 X 125-mm standard
bore electrophoresis tubes (i.d. 10.6 mm), which had
been acid washed, rinsed free of water, and dried. Before
pouring the gels, all reagents were brought to room tem-
perature, mixed quickly in an iron-free tube and poured into
a 13 X 125-mm electrophoresis tube and immediately lay-
ered with iron-free water to produce a flat surface on the
gel. Each tube contained 6 ml of 10 M urea, 2 ml acryl-bis,
1 ml of 10 X buffer (0.89 M Tris-0.89 M borate, pH 8.4), 0.5
ml 8% Temed and 0.5 ml 2% ammonium persulfate. After
polymerization, the electrophoretic cell (model 155, Bio-Rad
Laboratories) was assembled and precooled Tris borate-
buffer (1:10 dilution) was added. The cell was then attached
to a circulating cooling water bath set at 10°C and run at
100 V for 2 h for equilibration. 0.5 h before application time,
130 gl of the test plasma was mixed with 870 Ml of the su-
crose-containing diluting buffer. The electrophoretic cell
was turned off and 200 Al of this dilute solution was applied
beneath the buffer at the surface of the polyacrylamide col-
umn. Electrophoresis was resumed with 100 V power only
for -30 min to allow the protein to enter the gel, after
which cooling and stirring were resumed and electrophoresis
continued for 17 h. The gel was then removed from the glass
tube by rimming and was frozen. Each gel was cut into 50
slices, 2-mm thick. For 59Fe and 1251 counting, pieces were
placed in consecutive counting tubes and activity was de-
termined in a gamma counter. For samples containing 55Fe,
activity was extracted with 1 M perchloric acid and the fluid
along with scintillation fluid was placed in a tube for count-
ing in a Packard liquid scintillation counter (Packard In-
strument Co., Downers Grove, IL).
The uptake of iron from transferrin by reticulocytes dur-
ing in vitro incubation was studied (3, 4). To produce reticu-
locytosis, a rabbit was bled 60 ml from the ear artery on
days 1, 3, and 4 and blood obtained for the study on day 6.
The reticulocyte count of that blood was 29% and the he-
matocrit was 22. The blood was centrifuged in 4-ml aliquots
at 700 g, plasma removed, and cells washed once with 20
ml cold Hanks' balanced salt solution (HBSS). Purified trans-
ferrin labeled with both radioiodine and radioiron was di-
luted with HBSS until the plasma iron was -90±5 ,ug/dl.
The incubation mixture consisted of 2.5 ml of the individual
transferrin solution added to the washed packed erythrocytes
to give a hematocrit of -24%. The mixtures were kept on
ice for 10 min at which time an 0.5 ml zero-time sample was
taken, centrifuged at 4°C and the supernatant and eryth-
rocytes separated for analyses. The remaining tubes were
incubated at 37°C and sampled at 60 and 120 min. The
supernatant of all samples was subjected to electrophoretic
analysis. Because inaccurate results are obtained with very
diluted protein solutions, 0.1 ml of carrier rabbit plasma was
added to each 0.1 ml of supernatant and then 300 ul of
sucrose-containing buffer was added before application.
New Zealand male rabbits on a Purina (Ralston Purina
Co., St. Louis, MO) diet were used for in vivo studies. They
weighed between 1.5 and 3.2 kg. Mean hematocrits, plasma
iron, and total iron binding capacity measurements for 40
animals were 40.5±2.9 (mean±SD), 185±57 Mug/dl, and
323±35 MAg/dl, respectively. Additional observations were
made to determine the stability of the plasma iron concen-
tration. In six nonfasting animals, the average plasma iron
concentration was 255±57 ,ug/dl. After 12 h of fasting, these
same animals had a mean value of 157±53 ug/dl and after
24 h of fasting the mean concentration was 155±47 ug/dl.
In addition, the plasma iron was sampled every 4 h over a
24-h period in a second group of six animals. Mean changes
in plasma iron values beginning at 8:00 a.m. were 185±55,
195±61, 189±60, 171±62, 169±58, 168±45, and 172±33
ug/dl. It was concluded that food ingestion probably had a
significant effect on plasma iron level but that there was no
obvious diurnal change.
It was desirable in these studies to have widely varying
plasma iron concentrations. In some animals the plasma iron
was lowered by the intramuscular injection 12 h before of
0.5 ml of turpentine (T & R Chemical Inc., Clint, TX) or
0.5 Mg/kg of endotoxin (lipopolysaccharide, Salmonella ty-
phi 0901, Difco Laboratories, Detroit, MI). To obtain a high
plasma iron, a freshly prepared 4-ml solution of ferrous am-
monium sulfate at pH 2 was infused intravenously over a
period of 10 min by pump. The amount of iron injected was
calculated to raise the transferrin saturation to -80%.
Ferrokinetic measurements were carried out in animals
fasted overnight (8). In some studies, 1 ml of a solution of
ferrous sulfate containing 1-3 MCi radioiron in 0.1,Mg of iron
at pH 2 was injected intravenously over a 5-min period. In
other studies, a similar amount of radioiron bound in vitro
to 4 ml plasma or a solution containing purified transferrin
fractions labeled with radioiron was injected. Other exper-
imental formats involving simultaneous injection of several
labeled compounds are specified under Results. Thereafter,
five or six samples, 1 ml each were drawn for radioactive
measurements from the central artery of the ear into a hep-
arinized tube placed on ice, which was spun down within
the hour. The sampling time was adjusted to extend beyond
the anticipated t½/2 radioiron disappearance. In addition, 1.5
ml of blood was drawn at 10 min and repeated at the ap-
proximate ½h disappearance time and at twice that interval
for plasma iron determination. Some animals were sacrificed
by exsanguination 4 d later, at which time blood and tissue
samples were taken for radioactive measurements.
Samples containing 59Fe alone were analyzed directly in
a gamma counter. Those containing two isotopes were pre-
pared by first adding 0.25 ml plasma to 0.5 ml of 0.1 N
perchloric acid and then were centrifuged. 10 ml of Aquasol
(New England Nuclear, Boston, MA) was added to 0.5 ml
of the supernatant and samples were counted in a Tricarb
scintillation spectrometer (model 2405, Packard Instrument
Co.). Appropriate correction was made for cross-counting.
Tissues containing 55Fe and 59Fe were wet ashed and pre-
pared for liquid scintillation counting by the method of Eak-
ins and Brown (9).
Plasma iron turnover (PIT) was calculated as previously
described (10) according to the formula:
PIT (mg/dl whole blood/d)
Plasma iron (Mg/dl) 100 - (Hct X 0.9)
th(min) 100
Plasma iron was performed according to the methods of the
Standardization Committee of the International Society of
Hematology (11) and iron binding capacity according to
Cook (12). Hematocrits were determined by the microtech-
nique.
The kinetics of uptake and release by transferrin were
evaluated using transferrin tagged with 125I, monoferric
transferrin tagged with 59Fe, and diferric transferrin tagged
with 55Fe. These proteins, with their varying iron concen-
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trations, were injected simultaneously and the blood was
sampled to determine the relative amounts of each in the
electrophoretic profile as a function of time. On the basis
of preliminary observations it was concluded that three half-
time clearances of radioiron were sufficient to establish equi-
librium. Therefore, six samples were drawn during three
half-time clearances of radioiron and an additional sample
was taken at 24 h.
Mathematical considerations. If random distribution on
open transferrin sites is assumed, it is possible from the per-
cent saturation of transferrin to determine the proportion
of apo-, mono-, and diferric transferrin by the following
formulae developed in the Appendix:
S2 S(100 - S)
TfFe2 100 TfFel = 50
TfFeo = 100 - TfFel - TfFe2,
where TfFe2 = diferric transferrin, TfFel = monoferric
transferrin, TfFeo = apotransferrin, and S = percent trans-
ferrin saturation determined by plasma iron divided by total
iron binding capacity. To determine the amount of iron as
mono- and diferric transferrin, the relative percentages of
mono- and diferric transferrin must be corrected for the
double load of iron carried by diferric transferrin. This is
done as follows:
% Fe as TfFe1 = TfFel/TfFel + 2TfFe2 X 100;
the percent Fe in TfFe2 is given by the formula:
% Fe as TfFe2 = 2TfFe2/TfFe, + 2Tf Fe2 X 100.
In the prediction of in vivo transferrin iron interactions, it
was assumed that iron entering and leaving circulation par-
ticipated in four reactions, each with its own reaction con-
stant (Fig. 1). These included:
(1) binding of iron to apotransferrin to form monoferric
transferrin
(TfFeo - TfFel)
(2) binding of iron to monoferric to form diferric trans-
ferrin
(TfFe I TfFe2)
(3) monoferric iron released to tissues leaving apotrans-
ferrin
(TfFe1 A TfFeo)
(4) diferric iron released to tissues leaving apotransferrin
k4(TfFe2 -+ TfFeo).
Given information concerning transferrin saturation and the
in vivo radioiron disappearance rates of mono- and diferric
transferrin iron fractions, a model can be constructed to
predict iron distribution among transferrin binding sites as
a function of time. Briefly, the model uses four apparent
rate constants (k1 to k4) to describe the iron-transferrin in-
teraction by the reaction kinetic principles. The value of the
individual rate constants is determined for a particular rabbit
using the double-isotope technique. When the value of the
rate constants is known, it is possible to predict the iron
distribution among transferrin as a function of time. In ad-
dition, the model can be used to calculate the plasma iron
turnover for each animal. Details of the mathematics used
in these calculations are shown in the Appendix. A linear
Fe
FIGURE 1 Format of in vivo exchange: Apotransferrin is
converted to monoferric transferrin by uptake of one atom
of iron from an iron-donating tissue and may be subse-
quently converted to diferric iron by the addition of a second
iron atom. Iron is released to a membrane receptor from
either mono- or diferric transferrin, in both instances leaving
apotransferrin. The respective reaction constants for these
four reactions are designated ki through k4.
correlation coefficient was calculated for the predicted vs.
observed data. The correlation coefficient will approach 1.0
if the model accurately describes the physical process.
RESULTS
In vitro studies. Preliminary studies were carried
out in which 59FeSO4 was added in tracer amounts in
vitro to purified rabbit apotransferrin and to sidero-
penic rabbit plasma, as shown in Fig. 2. The sequential
changes in the relative amounts of apo-, mono-, and
diferric transferrin with increasing amounts of iron
were those predicted from random loading (13).
While the release of iron from monoferric transfer-
rin can only produce apotransferrin, release of iron
from diferric transferrin could either result in mono-
ferric or, if both iron atoms were released simulta-
neously, in apotransferrin. To evaluate this, diferric
rabbit transferrin was labeled with 1251 and 59Fe and
exposed to rabbit reticulocytes. Changes in the pro-
portions of diferric, monoferric, and apotransferrin are
summarized in Table I. Only apotransferrin was gen-
erated, indicating an all-or-none delivery of iron from
the two binding sites of the diferric transferrin in the
rabbit system.
In vivo studies. The plasma iron clearance from
monoferric transferrin A and monoferric transferrin
B was studied in six rabbits with a mean plasma iron
of 80±34 ,ug/dl and a saturation of 28±13%. The clear-
ance of monoferric A was 51±11 min vs. 48±11 for
monoferric transferrin B and the ratio between the
two clearances was 1.0±0.1. The tissue localization of
monoferric A in erythrocytes at 5 d was 84±27%, in
liver 7±3%, and in spleen 0.6±0.3% as compared with
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FIGURE 2 Distribution of iron between the molecular forms of rabbit transferrin. The data
were obtained by urea gel electrophoresis of (a) purified '251-labeled apotransferrin (2.5 mg/
ml in Hanks' balanced salt solution) and (b) raw iron rabbit plasma (SeFe 13 .g/dl, unsaturated
iron bindings capacity 337 ,g/dl) to which a tracer amount of '25I-apotransferrin (10 ,ug protein;
sp act 20 ,uCi 1251, 1 ng protein) has been added. To these solutions increasing amounts of ferrous
ammonium sulfate (39.2 usg Fe2f/ml in 0.01 N HCI) were added. Apotransferrin, (0); monoferric
transferrin, (A); diferric transferrin, (U); distribution predicted by the random model,
corresponding distributions of monoferric B of 82±2.5,
7±2, and 0.6±0.3%. In addition, a comparison between
the tissue distribution of iron injected in the differic
form as compared with that of monoferric B transfer-
rin showed similar iron distribution at 1 and 5 d. Re-
spective values for erythrocytes, liver, and spleen at
5 d were 89±1.8, 8±3, and 0.4±0.1% as compared with
88±1.9, 6+2, and 0.4±0.2%.
To determine the effect of plasma iron concentra-
tion on iron turnover, tandem turnover determinations
TABLE 1
Radioiron Uptake from Diferric Transferrin
by Rabbit Reticulocytes°
Original iron 'Fe lost from Apotransferrin
concentration Tinie 'Fe uptake diferric peak formed
iugidl min %
plasnw
89 60 48.5 47.0 37.9
120 68.1 71.3 61.7
193 60 25.4 24.5 20.6
120 37.1 37.2 31.5
e Release of iron from diferric transferrin was followed using elec-
trophoresis to quantitate the disappearance of 59Fe and protein-
labeled 1251 fromk the diferric peak and the localization of "I in
the apo- and monoferric peaks.
were carried out in two groups of animals before and
after the intravenous injection of ferrous ammonium
sulfate. Care was taken that the distribution of isotope
between mono- and diferric transferrin was similar to
that present in the animal. Two groups of animals were
studied, eight with plasma tagging in vivo and five
with plasma tagging in vitro. Base-line turnover values
at mean plasma iron concentrations of 137 and 148
,ug/dl were 1.55 and 1.59 mg/dl whole blood per d.
At artificially elevated plasma iron concentrations av-
eraging 248 and 272, turnover values had increased
to 2.0 and 2.1 mg/dl whole blood per d, respectively.
The overall relationship between plasma iron and
plasma iron turnover in these two studies and in ad-
ditional observations on monoferric and diferric re-
lationships is shown in Fig. 3.
The relationship between individual clearance rates
of mono- and diferric transferrin at low and high levels
of saturation is described in Fig. 4. There were marked
differences in clearance rate at low saturations re-
gardless of whether purified plasma fractions or plasma
labeling was used, whereas at high transferrin satu-
rations there was little difference.
The in vivo distribution at equilibrium of iron on
transferrin binding sites was monitored 24 h after the
injection of '251-tagged apotransferrin (Table II). The
predicted distribution based on random loading at the
transferrin saturation of each animal was compared
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FIGURE 3 Relationship between plasma iron concentration
and plasma iron turnover. These observations were made in
three groups of animals and included both in vitro and in
vivo radioiron labeling of transferrin. Each point represents
a single determination of plasma iron turnover.
with that found by gel electrophoresis. A close agree-
ment was found (r = 0.99; P < 0.0001).
The loading and unloading of iron on the transferrin
molecule in vivo was examined in more detail by mea-
suring sequential changes in '251-labeled apotransferrin
after its intravenous injection in tracer amounts. A typ-
ical study is shown in Fig. 5. The observed changes
were then compared with those predicted from our
model that used the transferrin saturation and indi-
vidual clearances of 59Fe-labeled monoferric transfer-
rin and 55Fe-labeled diferric transferrin. The relation
0
Clearance rate ratio
DIerric
2.0-
1.5 -
1.0 -
between experimental data based on labeled transfer-
rin and model estimates is shown in Fig. 6.
The derived constants for conversion of apo- to
mono- (k1), from mono- to di- (k2), from mono- to apo-
(k3), and from diferric to apotransferrin (k4) in 13 an-
imals are shown in Table III. The value of each rate
constant and their ratios were strongly dependent on
the animal's transferrin saturation (Appendix).
DISCUSSION
Transferrin is responsible for iron exchange within the
body and has been assumed to function kinetically as
a single iron pool (14). However, chemical differences
between the two iron binding sites have been de-
scribed, and it has been suggested that site differences
in iron loading and unloading might also occur in vivo
(2). Because the behavior of transferrin is critical in
isotopic measurements of internal iron exchange and
particularly in calculations of erythron iron exchange,
detailed studies have been carried out by us in several
animal species to define transferrin iron behavior.
In the studies reported here, iron added to trans-
ferrin has been shown to load randomly on the two
iron binding sites. The in vivo distribution of iron be-
tween sites has also been shown to be that predicted
on the basis of random loading (Table II). Iron uptake
must therefore occur one atom at a time; otherwise
there would be a disproportionate amount of diferric
transferrin present as compared with the proposed ran-
dom distribution found. This same in vitro and in vivo
loading pattern has been observed in other species (4,
15). The release of iron from transferrin to reticulo-
Transferrin Saturation ( % )
s0 100
I A
0 10o 300
Pasma Iron (Ag/dl )
FIGURE 4 Effect of plasma iron and transferrin saturation on clearance rate ratio of diferric
to monoferric transferrin. The clearance of diferric transferrin was compared in 12 animals
with a preparation of a mixture of monoferric a and b transferrin (0) and in 16 animals with
a monoferric b transferric preparation (0). Each point represents the mean of four to six values
and the horizontal bars the limits of 1 SD.
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TABLE II
Proportions of Apo-, Mono-, and Diferric Transferrin Measured at Equlibrium
Compared to that Predicted from the Transferrin Saturation, Assuming
Random Distribution of Iron on Binding Sites
Measured Predicted
Rabbit Transferrin
code no. saturation Tfo TfFel TfFe, Tfo TfFel TfFe,
NAI 36 43 40 16 47 40 13
BEI 45 29 52 19 30 50 20
MAZ 16 73 23 4 71 26 5
BEZ 51 24 50 26 24 50 26
MAS 20 64 32 4 64 32 4
BE3 93 2 11 87 0 14 86
MA4 57 18 48 33 18 50 32
BE4 81 6 26 68 4 30 66
cytes in vitro has been shown to be an "all-or-none
phenomenon." This is also similar to the behavior of
transferrin in other species (3, 4, 15). Furthermore, the
distribution of iron to different tissues from the two
iron binding sites has been shown to be similar in the
100
80
60
S
IC
40
20
20
rabbit, again in agreement with results in other species
(15-17).
The consistency of the in vivo behavior of transfer-
rin in these different species suggests a common model
for iron transport. This involves two pathways, the first
0 20 40 60 80 100 120
time ( min )
FIGURE 5 Representative example of the loading of injected rabbit '251-apotransferrin with
iron in vivo as a function of time. Purified 125I-apotransferrin (15 ,uCi, sp act 20 MCi/mg protein,
was injected in the ear vein of a rabbit. Body wt 1,878 g; serum iron 135,ug/dl; iron saturation
48%). At various intervals heparinized blood samples were taken from the central artery of the
ear and centrifuged. Plasma samples were subjected to urea gel electrophoresis and the dis-
tribution of iron between the molecular forms of rabbit transferrin was determined (Methods).
Apotransferrin, (-); monoferric transferrin, (A); diferric transferrin, (-).
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FIGURE 6 A comparison of values derived from the conversion of I251-apotransferrin to other
transferrin moieties vs. values predicted from the mathematical model. The model used the
percent rabbit transferrin saturation and the t'/2 for 55Fe and 59Fe to predict the apo- (0), mono-
(-), and diferric transferrin (X) as a function of time. Quantitation of the distribution of 1251_
tagged transferrin was achieved by electrophoresis. Results in four animals showed close agree-
ment, r = 0.94.
represented by the loading and delivery of a single at the receptor site. At low transferrin saturations,
molecule of iron and the second a sequential loading where most open sites exist on apotransferrin, the pre-
of two atoms of iron with their simultaneous release dominant pathway is monoferric. At high saturations
TABLE III
Rate Constants Derived from the Disappearance of Radioiron
from Mono- and Diferric Transferrin
Rabbit
code no. S k, k, k3 k1/kl k3/k4
MA2 10 0.0067 0.0035 0.0265 0.0622 1.9 2.3
MA3 20 0.0073 0.0028 0.0117 0.0224 2.6 1.9
x4 30 0.0114 0.0044 0.0089 0.0207 2.6 2.3
x3 35 0.0231 0.0077 0.0134 0.0294 3.0 2.2
MAI 45 0.0155 0.0043 0.0050 0.0108 3.6 2.2
BEL 48 0.0231 0.0060 0.0065 0.0130 3.9 2.0
BE2 50 0.0284 0.0064 0.0078 0.0127 4.4 1.6
Xi 56 0.0439 0.0089 0.0078 0.0143 4.9 1.8
MA4 59 0.0361 0.0068 0.0060 0.0094 5.3 1.6
X2 64 0.0736 0.0119 0.0089 0.0134 6.2 1.5
BE4 78 0.1450 0.0143 0.0070 0.0080 10.1 1.1
BES 93 ' 1.0 0.0339 0.0057 0.0055 9.7 1.0
X5 99 0c 0.2260 0.0050 0.0056 00 1.1
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where most of the open sites are on monoferric trans-
ferrin, the predominant pathway is diferric. The other
consideration is the greater capacity of diferric trans-
ferrin to deliver iron to tissues. The proportion of iron
delivered by monoferric transferrin and the absolute
amounts of iron exchanged by mono- and diferric
transferrin at different transferrin saturations are
shown in Figs. 7a and 7b. At a transferrin saturation
of 50%, where precisely half of the iron would be
monoferric and half diferric, two-thirds of the iron
would be delivered by diferric transferrin. Since half
as many diferric transferrin molecules deliver twice
as much iron, the efficiency of the diferric moiety is
about four times that of its monoferric counterpart.
100'
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s o60-
40
20O
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0
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FIGURE 7 Iron delivery from mono- and diferric transferrin.
Data from constants (kl-k4) derived from studies in exper-
imental animals are used to calculate the relation between
plasma iron turnover and the respective proportions con-
tributed by mono- and diferric transferrin. Fig. 7a indicates
the decreasing amount of iron delivered to tissues from
monoferric iron with increasing transferrin saturation. Fig.
7b indicates the absolute amounts of iron delivered by nor-
mal animals as a function of transferrin saturation. The three
curves in Fig. 7b represent total plasma iron turnover (X),
diferric iron turnover (-), and monoferric iron turnover
(0).
This underlines the dominant role played by diferric
transferrin in iron transport and explains the progres-
sive increase in plasma iron turnover observed with
increasing plasma iron concentrations and transferrin
saturation.
In these studies of normal rabbits, iron supply may
be presumed to be more than adequate since the half-
time radioiron disappearance indicates a low rate of
iron extraction from the plasma (1). Nevertheless, the
plasma iron turnover increases with a larger proportion
of diferric transferrin. Thus, while tissue require-
ments, which are the primary determinant of plasma
iron turnover, remain unchanged, turnover can change
as a function of transferrin saturation. The latter effect
is mathematically predictable from the formula:
Converted PIT = Observed PIT
+ (plasmatocrit X PI)/100 X 0.00475.
Using such correction it is possible to define tissue iron
requirements independent of plasma iron concentra-
tion and to compare one animal's requirements with
another. This is particularly relevant to measurements
of erythropoiesis. A close correlation has been observed
between the number of erythroid precursors (18) or
the rate of erythrocytes production (10) and the plasma
iron turnover. This relationship should become all the
more significant when the effect of plasma iron con-
centration on iron uptake is removed.
APPENDIX
Derivation of mathematical models
Percentages of apo-, mono-, and diferric transferrin in
plasma. Let i = total number of iron molecules in the sys-
tem; t = total number of transferrin binding sites in the sys-
tem; s = probability that a transferrin site is filled by iron.
Assuming that any iron molecule has an equal probability
of filling any open transferrin binding site and that all iron
molecules are rapidly bound to a site,
s = i/t. (1)
The subject's percent saturation, S, equals 100 (i/t), or
S = 100 s. (2)
From probability theory, if s is the probability that one trans-
ferrin site is filled by iron, then s2 = probability that both
sites on a transferrin molecule are filled with iron molecules.
In this system, S2 also equals the fraction of diferric trans-
ferrin molecules. Converting to percent saturation,
TfFe2 = S2/100, (3)
where TfFe2 = percent diferric transferrin.
Since s represents the total probability of a transferrin
binding site being filled with iron, and s2 represents the prob-
ability that both sites on the transferrin molecule are filled
with iron, then
s-s2 = probability that only one transferrin site
is filled with iron. (4)
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Since each transferrin molecule has two potential binding
sites, the fraction of transferrin molecules with exactly one
binding site filled with iron is twice the probability of that
event occurring, or
2(s -s2) = fraction of monoferric transferrin molecules. (5)
Converting to percent saturation
TfFe, = S(100 - S)/50, (6)
where TfFel = percent monoferric transferrin. Since the
sum of all of the transferrin must equal 100%,
TfFeo = 100 - TfFe, - TfFe2, (7)
where TfFeo = percent apotransferrin.
Percentage of mono- and diferric iron. Eqs. (7), (6), and
(3) allow one to calculate the percentage of transferrin in
the apo-, mono-, and diferric states. To calculate the per-
centage of iron present in monoferric and diferric states,
considerations must be given to the fact that TfFe2 has twice
the iron as TfFe,. Thus,
% Fe as TfFel = TfFe+ 100 (8)TfFe, + 2TfFe2
2TfFe2% Fe as TfFe2 =TfFe, + 2TfFe2
To illustrate the above formulas, suppose the subject's sat-
uration is 40%. Then
(40)2TfFe2 = ( = 16%100
40(100 - 40)TfFe=F400 - = 48%50
TfFe0 = 100 - 48 - 16 = 36%
48% Fe asTfFe,= 100=60%48 + 2(16)
% Fe as TfFe2 = (1) 100 =40%48 + 2(16)
Kinetic model. The random loading model describes the
iron distribution at steady state. However, the random model
tells nothing of the dynamics of iron binding to transferrin
and its subsequent release to tissues. To better understand
this kinetic process, a model has been developed that uses
reaction kinetic principles to describe the iron-transferrin
interactions by a series of rate constants. The kinetic model
assumes that iron and transferrin interact in four ways as
indicated by the following four equations:
(a) an iron molecule binds to apotransferrin to form
monoferric transferrin,
TfFeo + Fe-- TfFe, (10)
(b) a second iron molecule binds to monoferric transferrin
to form diferric transferrin,
TfFe, + Fe - TfFe2 (1 1)
(c) iron is delivered to the tissues by monoferric trans-
ferrin,
TfFe, -' TfFeo + Fe-tissues (12)
(d) iron is delivered to the tissues by diferric transferrin,
TfFe2 -' TfFeo + 2Fe-tissues,
where Tf, transferrin; Fe, free iron; and kx, reaction rate
constant.
The model assumes a constant Fe concentration, meaning
that the iron saturation cannot change significantly during
the course of an experiment. Both k1 and k2 are "apparent"
rate constants since the conversion of apo- to mono- and
mono- to diferric transferrin involves reaction with a free
ion. Thus, k1 = k'1Fe and k2 = k'2Fe1 where Fe is the free iron
concentration and k' and k2 are the true rate constants. Since
the model requires a constant free iron concentration, we
have chosen to use the apparent rate constants for simplicity.
The differential equations describing the interactions of
(10)-(13) are:
d(fFe) = -kTfFe0 + k3TfFej + k4TfFe2
dt
d(f F1) = k1TfFe0 - (k3 + k2)TfFe,dt
dfFe)= k2TfFe1 - k4TfFe2.-dt
(14)
(15)
(16)
Eqs. (14)-(16) form the basis of the kinetic model. If the
rate constants ki, k2, k3, and k4 are known, then the equations
can be solved numerically to give the concentration of
apo-, mono-, and diferric transferrin at any time t. This
fulfills the purpose of the model: to predict the iron distri-
bution as a function of time.
To calculate the values of the individual rate constants,
consider first the steady-state or equilibrium condition of the
system. Since Eqs. (14)-(16) must be valid at all times, it
follows that the relationship represented in these equations
is true at equilibrium when
d(Tf Feo) d(TfFe1) d(TfFe2)
d
= =
dtdt dt dt (17)
In other words, equilibrium means that as TfFe, is removed
from the system either by conversion to TfFe2 or by removal
to the tissue, then a new TfFel is created from TfFeo to
replace it. By examining the steady-state condition, two re-
lationships between the rate constants become apparent.
From Eq. (16): k2 = k, TfFe2/TfFe,
From Eq. (15): ki = (k3 + k2)TfFel/TfFeo.
(18)
(19)
To find the values of k3 and k4 for a particular subject, we
require some experimental data, in particular, the decay
rates of two types of tagged iron from the subject. One of
the irons, say 55Fe, must be injected as nearly pure diferric.
The other tag, say 59Fe, can have any mono/di distribution,
so long as that distribution is known. In following the decay
of tagged iron, Eq. (14) describing apotransferrin has no
relevance since it contains no tag. Thus, when using tagged
iron, Eqs. (14)-(16) can be simplified to:
d(TfdFei) = -(k3 + k2)TfFe1dt
d(fe)= k2Tf Fe, - k4Tf Fe2 ,dt
(20)
(21)
where the asterisk indicates radioactively tagged iron. For
pure diferric transferrin (tagged with 55Fe in this example)
Tf55Fe, = 0, and Eq. (21) becomes
d(TfmFe2)--k(Tf5Fe2).
dt(13) (22)
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FIGURE 8 Relationship between the reaction rate constants and transferrin saturation. The
constants related to the uptake of iron by monoferric (kl) or diferric (k2) transferrin show a
positive correlation (r = 0.96 and r = 0.92, respectively) (a) as well as their ratio (r = 0.98)
(c). The constants related to the iron release by mono- (k3) or diferric (k4) transferrin show a
negative correlation (r = -0.69 and r = -0.92, respectively (b). The ratio between these last
show a similar negative correlation (r = -0.88) (d).
This equation can be directly solved in terms of the decay
half-time of 55Fe:
In(2)
k4 = 55 ( ) (23)
1t/2
Thus, the decay half-time of the diferric tag gives the value
of k4 directly.
The value of k2 is found from Eq. (18). Since the percent
saturation of the subject is measured, TfFel and TfFe2 are
calculated from Eqs. (6) and (3). Using the k4 value from
Eq. (23) gives k2 directly.
The most difficult rate constant to determine is k3. Eqs.
(20) and (21) can be solved for Tf*Fel and Tf°Fe2 as a
function of time by assuming a value for k3 (k2 and k4 have
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been determined already). The simultaneous differential
equations can be solved by a variety of numerical methods
such as the Newton or Runga-Kutta technique. Experimen-
tally, the decay of 5"Fe is the sum of Tf59Fel + TF59Fe2. A
series of k3 values are used and (Tf59Fel + Tf59Fe2) is found
from the solution of Eqs. (20) and (21). The k3 value that
gives the best fit to the experimental data is determined. For
the rabbit data, a modified Newton procedure was used to
find the ks that gave the closest estimation of the tlh for 59Fe.
This is a relatively simple procedure on a programmable
calculator. The value of kl, the remaining fourth rate con-
stant, was calculated from Eq. (19). Values of the constants
calculated as a function of transferrin saturation in the in-
dividual experiments are shown in Fig. 8.
Once the rate constants have been determined for a par-
ticular subject, the value of TfFeo, TfFel, and TfFe2 at any
time can be calculated from Eqs. (14)-(16) using a numerical
method such as the modified Newton procedure. The ac-
curacy of the model in predicting the iron-loading distri-
bution as a function of time has been described in the text.
The plasma iron turnover can also be calculated from the
kinetic model. Knowing k2, k3, and k4, Eqs. (20) and (21) can
be used to find the t½ for the saturation of the patient, and
the PIT is calculated from this t½ value. The advantage of
this method is that it finds the t½ for the subject's percent
saturation, which can differ significantly from the t½ of the
tagged iron. As discussed in the text, the t' is a function of
the saturation of the tagged iron. Unless the tagged iron has
a saturation identical to the subject's saturation, the mea-
sured t½ will be in error. Use of the kinetic model, though
a more complex procedure, will give a more accurate de-
termination of the PIT.
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